AAAAAA
Results:
1-15
|
Results: 15
Authors:
Nakazato, A
Kumagai, T
Okubo, T
Tanaka, H
Chaki, S
Okuyama, S
Tomisawa, K
Citation: A. Nakazato et al., Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor(1) receptor antagonists, BIO MED CH, 8(5), 2000, pp. 1183-1193
Authors:
Murakami, S
Muramatsu, M
Tomisawa, K
Citation: S. Murakami et al., Inhibition of gastric H+, K+-ATPase by flavonoids: A structure-activity study, J ENZ INHIB, 14(2), 1999, pp. 151-166
Authors:
Funakoshi, T
Chaki, S
Okuyama, S
Okubo, T
Nakazato, A
Nagamine, M
Tomisawa, K
Citation: T. Funakoshi et al., In vivo receptor labeling of peripheral benzodiazepine receptor by ex vivobinding of [H-3]PK11195, RES COM M P, 105(1-2), 1999, pp. 35-41
Authors:
Murakami, S
Kondo, Y
Tomisawa, K
Nagate, T
Citation: S. Murakami et al., Prevention of atherosclerotic lesion development in mice by taurine, DRUG EXP CL, 25(5), 1999, pp. 227-234
Authors:
Kawashima, N
Nakamura, A
Okuyama, S
Chaki, S
Tomisawa, K
Citation: N. Kawashima et al., Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain, GEN PHARM, 32(6), 1999, pp. 637-646
Authors:
Chaki, S
Funakoshi, T
Yoshikawa, R
Okuyama, S
Kumagai, T
Nakazato, A
Nagamine, M
Tomisawa, K
Citation: S. Chaki et al., In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats, NEUROPHARM, 38(8), 1999, pp. 1185-1194
Authors:
Kawashima, N
Okuyama, S
Omura, T
Chaki, S
Tomisawa, K
Citation: N. Kawashima et al., Effects of selective dopamine D-4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats, LIFE SCI, 65(24), 1999, pp. 2561-2571
Authors:
Okuyama, S
Kawashima, N
Chaki, S
Yoshikawa, R
Funakoshi, T
Ogawa, S
Suzuki, Y
Ikeda, Y
Kumagai, T
Nakazato, A
Nagamine, M
Tomisawa, K
Citation: S. Okuyama et al., A selective dopamine D-4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile, LIFE SCI, 65(20), 1999, pp. 2109-2125
Authors:
Okuyama, S
Chaki, S
Yoshikawa, R
Ogawa, S
Suzuki, Y
Okubo, T
Nakazato, A
Nagamine, M
Tomisawa, K
Citation: S. Okuyama et al., Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106, LIFE SCI, 64(16), 1999, pp. 1455-1464
Authors:
Okuyama, S
Chaki, S
Kawashima, N
Suzuki, Y
Ogawa, SI
Nakazato, A
Kumagai, T
Okubo, T
Tomisawa, K
Citation: S. Okuyama et al., Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001, J PHARM EXP, 289(2), 1999, pp. 926-935
Authors:
Nakazato, A
Kumagai, T
Ohta, K
Chaki, S
Okuyama, S
Tomisawa, K
Citation: A. Nakazato et al., Synthesis and SAR of 1-alkyl-2-phenylethylamine derivatives designed from N,N-dipropyl-4-methoxy-3-(2-phenylethoxy)phenylethylamine to discover sigma(1) ligands, J MED CHEM, 42(19), 1999, pp. 3965-3970
Authors:
Murakami, S
Nitanai, I
Uchida, S
Kondo-Ohta, Y
Asami, Y
Kondo, K
Sato, M
Kawashima, A
Hara, P
Tomisawa, K
Mei, HB
Xiang, CZ
Citation: S. Murakami et al., Up-regulation of low density lipoprotein receptor by a novel isobenzofranone derivative, MD-700, ATHEROSCLER, 146(2), 1999, pp. 281-290
Authors:
Chaki, S
Funakoshi, T
Yoshikawa, R
Okuyama, S
Okubo, T
Nakazato, A
Nagamine, M
Tomisawa, K
Citation: S. Chaki et al., Binding characteristics of [H-3]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors, EUR J PHARM, 371(2-3), 1999, pp. 197-204
Authors:
Chaki, S
Okuyama, S
Nakazato, A
Kumagai, T
Okubo, T
Ikeda, Y
Oshida, Y
Hamajima, Y
Tomisawa, K
Citation: S. Chaki et al., In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001, EUR J PHARM, 371(2-3), 1999, pp. 205-211
Authors:
Murakami, S
Kondo-Ohta, Y
Tomisawa, K
Citation: S. Murakami et al., Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet, LIFE SCI, 64(1), 1998, pp. 83-91
Risultati:
1-15
|